DEF 14A

Company

Vistagen Therapeutics, Inc.

Filed

August 11, 2015

Period of Report

August 11, 2015

Accession Number

0001415889-15-002609

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →